Keyphrases
Asian Diabetes
10%
Bariatric Surgery
24%
Blood Glucose
6%
Body Mass Index
13%
Cardiovascular Disease
9%
Cardiovascular Events
6%
Cardiovascular Mortality
6%
Cardiovascular Outcomes
7%
Cardiovascular Risk
11%
Cholesterol
11%
Chronic Kidney Disease
11%
Clinical Course
5%
Coronavirus Disease (COVID)
6%
Diabetes
36%
Diabetes Management
12%
Diabetic Ketoacidosis
8%
Exubera
7%
Frailty
8%
Glucose Level
7%
Glycemic Control
11%
Glycemic Outcomes
5%
Hemoglobin A1c (HbA1c)
19%
Human Insulin
6%
Hypoglycemia
14%
Inhaled Insulin
13%
Insulin
10%
Insulin Resistance
6%
Insulin Therapy
10%
Irisin
7%
Meta-analysis
7%
Multi-ethnic
5%
Nephropathy
6%
Obesity
12%
Older Adults
14%
Patients with Diabetes
19%
Placebo
6%
Risk Factors
8%
Semaglutide
8%
South Asian
41%
South Asian Population
13%
Telomere Length
8%
Triglycerides
6%
Type 1 Diabetes Mellitus (T1DM)
15%
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetic Patients
32%
Type I Diabetes
9%
United Kingdom
9%
Vascular Complications
8%
Weight Loss
8%
White European
17%
Medicine and Dentistry
Bariatric Surgery
27%
Blood Pressure
5%
Body Mass Index
10%
Canagliflozin
8%
Cardiovascular Disease
16%
Cardiovascular Risk
12%
Cardiovascular System
16%
Chronic Kidney Disease
8%
Clinical Trial
7%
Cohort Analysis
7%
Comorbidity
5%
COVID-19
8%
Diabetes
64%
Diabetes Mellitus
7%
Diabetic Nephropathy
6%
Diseases
8%
End Stage Renal Disease
5%
Frailty
10%
Geriatrics
5%
Glomerular Filtration Rate
5%
Glycemic
8%
Glycemic Control
8%
Hazard Ratio
6%
Hemoglobin A1c
11%
Human Insulin
6%
Hypoglycemia
10%
Insulin Dependent Diabetes Mellitus
7%
Insulin Treatment
11%
Light Chain
5%
Lung
5%
Maturity Onset Diabetes of the Young
71%
Meta-Analysis
8%
Microvascular Complication
8%
Nephropathy
9%
Obesity
6%
Patient with Diabetes
8%
Patient with Obesity
5%
Patient with Type 2 Diabetes
21%
Prevalence
10%
Primary Health Care
7%
Quality of Life
7%
Randomized Controlled Trial
7%
Recombinant Human Insulin
14%
Retrospective Cohort Study
7%
Smoking
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Systematic Review
5%
Triacylglycerol
7%
Type 2 Diabetes
7%
Weight Management
10%